Compounds which modulate the CB2 receptor

Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

Saved in:
Bibliographic Details
Main Authors ERMANN MONIKA, JENKINS JAMES EDWARD, BERRY ANGELA, PALMER CHRISTOPHER FRANCIS, PARKE CHANDANA, MUSHI INNOCENT, RIETHER DORIS, CIRILLO PIER FRANCESCO, THOMSON DAVID, ZINDELL RENEE M, BLUMIRE NIGEL, HICKEY EUGENE RICHARD, TAYLOR MALCOLM
Format Patent
LanguageEnglish
Published 09.09.2014
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Bibliography:Application Number: US201113022866